Athanassios Alevizopoulos
Amministratore Delegato presso TheraPten Biosciences, Inc.
Profilo
Athanassios Alevizopoulos is the founder of TheraPten Biosciences, Inc. He currently holds the title of Chairman & Chief Executive Officer at the company, which was founded in 2016.
Posizioni attive di Athanassios Alevizopoulos
| Società | Posizione | Inizio |
|---|---|---|
TheraPten Biosciences, Inc.
 TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada. | Amministratore Delegato | 23/02/2016 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
TheraPten Biosciences, Inc.
TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada. | Health Technology |
- Borsa valori
- Insiders
- Athanassios Alevizopoulos
